Up to 30% off — ends 7 Aug

ONLY00h00m00s

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Alexy Inciarte

University of Barcelona

This profile is automatically generated from trusted academic sources.

Google Scholar

How do I reach out?

Meet Kite AI

Contact this professor

Research Interests

Pharmacotherapy

Pharmacology

Antiviral Therapy

Drug Repurposing

Antiretroviral Therapy

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles18

Collaborators7

Antonella d'Arminio Monforte

Full Professor

Università degli Studi di Torino

Josep Mallolas Masferrer

Professor of Medicina

University of Barcelona

MARIANO ESTEBAN

Centro Nacional de Biotecnología

Montserrat Laguno Centeno

Institut d'Investigacions Biomèdiques August Pi i Sunyer

David Garcia-Hernandez

Associated Professor

Universitat Autònoma de Barcelona Facultat de Medicina

ESTEBAN MARTINEZ

Senior Consultant & Associate Professor of Medicine

john lambert

University College Dublin

How do I reach out?

Meet Kite AI

Alexy Inciarte

Associated profesor

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles18

Efficacy and safety of raltegravir plus lamivudine maintenance therapy.

Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 year

Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study

Larva migratoria, un diagnóstico poco común en viajeros

Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations

Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score–Matched Analysis

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)

Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study

Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study

Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals

Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020

The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses

Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.

Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with <scp>HIV</scp>: Real‐world insights from <scp>BICSTaR</scp> cohorts

Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience.

Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study

Amphetamine-related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020.

PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.

Collaborators7

Antonella d'Arminio Monforte

Josep Mallolas Masferrer

MARIANO ESTEBAN

Montserrat Laguno Centeno

David Garcia-Hernandez

ESTEBAN MARTINEZ

john lambert

How do I reach out?